EGFR and cancer: The most crucial RTKs include epidermal growth factor receptor (EGFR), insulin like growth factor receptor (IGFR), platelet-derived growth factor receptor (PDGFR), vascular endothelial growth factor (VEGF) and nerve growth factor receptor (NGFR), which are the current targets in developing cancer therapeutics particularly for GBM.